PlainRecalls
FDA Drug Moderate Class II Terminated

Valsartan tablets 160 mg, 90-count bottle, Rx Only, Repackaged by H.J. Harkins Co, Inc. Grover Beach, CA 93433, NDC 43547-0369-09. Tablet is yellow, capsule-shaped, biconvex, film-coated tablets debossed with 343 on one side and HH on the other side.

Reported: August 8, 2018 Initiated: July 26, 2018 #D-1022-2018

Product Description

Valsartan tablets 160 mg, 90-count bottle, Rx Only, Repackaged by H.J. Harkins Co, Inc. Grover Beach, CA 93433, NDC 43547-0369-09. Tablet is yellow, capsule-shaped, biconvex, film-coated tablets debossed with 343 on one side and HH on the other side.

Reason for Recall

Carcinogen impurity detected in API used to manufacture drug product.

Details

Units Affected
540 tablets
Distribution
Product was distributed to a physician's office.
Location
Grover Beach, CA

Frequently Asked Questions

What product was recalled?
Valsartan tablets 160 mg, 90-count bottle, Rx Only, Repackaged by H.J. Harkins Co, Inc. Grover Beach, CA 93433, NDC 43547-0369-09. Tablet is yellow, capsule-shaped, biconvex, film-coated tablets debossed with 343 on one side and HH on the other side.. Recalled by H J Harkins Company Inc dba Pharma Pac. Units affected: 540 tablets.
Why was this product recalled?
Carcinogen impurity detected in API used to manufacture drug product.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 8, 2018. Severity: Moderate. Recall number: D-1022-2018.